Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 11;9(38):21616-21625.
doi: 10.1039/c9ra03514a.

Chemical constituents from the stems of Machilus philippinensis Merr. and the neuroprotective activity of cinnamophilin

Affiliations

Chemical constituents from the stems of Machilus philippinensis Merr. and the neuroprotective activity of cinnamophilin

Shih-Huang Tai et al. RSC Adv. .

Abstract

The Machilus genus (Lauraceae) had been extensively utilized in folk medicine due to its broad range of bioactivities. In the present study, a series of chromatographic separations of the methanol extract of stems of M. philippinensis led to the identification of thirty eight compounds totally. Among these, biscinnamophilin (1), machilupins A-C (2-4), machilutone A (5), and machilusoxide A (6) were new compounds reported for the first time. In addition, 5 was characterized with a unprecedented carbon skeleton. Other known compounds, including the major compounds cinnamophilin (7) and meso-dihydroguaiaretic acid (8), are identified by comparison of their physical and spectroscopic data with reported values. One of the reported compounds, cinnamophilin A (10), should be revised as dehydroguaiaretic acid (9) after careful comparison of all the 1H and 13C NMR data. Moreover, the neuroprotective activity of cinnamophilin (7) was examined in a primary cortical neuron culture and the results indicated that 7 was effective against glutamate induced excitotoxicity.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts to declare.

Figures

Fig. 1
Fig. 1. Chemical structures of new compounds 1–6 and 7.
Fig. 2
Fig. 2. Significant COSY, HMBC and NOESY correlations of 1–6.
Fig. 3
Fig. 3. The plausible biosynthetic mechanism of new lignans 2–5.
Fig. 4
Fig. 4. Cinnamophilin (7) reduced the glutamate-stimulated neuronal death in the concentration-dependent manner. PI uptake in cell culture was shown. (A) Primary cortical neurons treated DMSO 20 min then replaced with fresh medium as control. (B) Primary cortical neurons treated DMSO, (C) 1, (D) 3, (E) 10 μM 7 and (F) 20 μM MK-801, after 20 min added 300 μM glutamate for 6 h, n = 6.
Fig. 5
Fig. 5. Cinnamophilin (7) reduced the glutamate-stimulated neuronal death in the concentration-dependent manner. Trypan blue uptake in cell culture was shown. (A) Primary cortical neurons treated DMSO 20 min then replaced with fresh medium as control. (B) Primary cortical neurons treated DMSO, (C) 1, (D) 3, (E) 10 μM 7 and (F) 20 μM MK-801, after 20 min added 300 μM glutamate for 6 h, n = 4.
Fig. 6
Fig. 6. Cinnamophilin (7) reduced the glutamate-stimulated neuronal death in the concentration-dependent manner. Trypan blue in cell released out by treating 1% Triton X-100 and measured the absorbance at 600 nm. Data are expressed as percentage of control optical density (OD) values. Bars represent the mean ± SD, n = 4. *Significantly different from activated control cultures (one-way ANOVA followed by LSD test, P < 0.05).
Fig. 7
Fig. 7. Cinnamophilin (7) reduced the glutamate-stimulated neuronal death in the concentration-dependent manner. After primary cortical neurons in culture were treated 7 (1, 3 and 10 μM) or MK-801 (20 μM) and all were exposed to glutamate (300 μM), culture medium was removed and then sampled for LDH by measuring the absorbance at 490 nm. Data are expressed as percentage of control optical density (OD) values. Bars represent the mean ± SD, n = 6. *Significantly different from activated control cultures (one-way ANOVA followed by LSD test, P < 0.05).

Similar articles

Cited by

References

    1. Demaerschalk B. M. Yip T. R. Stroke. 2005;36:2500–2503. doi: 10.1161/01.STR.0000185699.37843.14. - DOI - PubMed
    1. Gladstone D. J. Black S. E. Hakim A. M. Stroke. 2002;33:2123–2136. doi: 10.1161/01.STR.0000025518.34157.51. - DOI - PubMed
    1. Schaller B. Free Radical Biol. Med. 2005;38:411–425. doi: 10.1016/j.freeradbiomed.2004.10.032. - DOI - PubMed
    1. Yu S. M. Ko F. N. Wu T. S. Lee J. Y. Teng C. M. Eur. J. Pharmacol. 1994;256:85–91. doi: 10.1016/0014-2999(94)90620-3. - DOI - PubMed
    1. Yu S. M. Wu T. S. Teng C. M. Br. J. Pharmacol. 1994;111:906–912. doi: 10.1111/j.1476-5381.1994.tb14824.x. - DOI - PMC - PubMed